The Rising Challenge of Non-AIDS-Defining Cancers in HIV-Infected Patients

被引:166
作者
Deeken, John F. [1 ]
Tjen-A-Looi, Angelique [2 ]
Rudek, Michelle A. [4 ]
Okuliar, Catherine [3 ]
Young, Mary [2 ]
Little, Richard F. [5 ]
Dezube, Bruce J. [6 ]
机构
[1] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Div Hematol Oncol, Washington, DC 20007 USA
[2] Georgetown Univ, Med Ctr, Div Infect Dis, Washington, DC 20007 USA
[3] Georgetown Univ, Med Ctr, Div Internal Med, Washington, DC 20007 USA
[4] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[5] NCI, Clin Invest Branch CTEP, Bethesda, MD 20892 USA
[6] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med Hematol Oncol, Boston, MA 02215 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SQUAMOUS-CELL CARCINOMA; HEPATITIS-C VIRUS; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; POSITIVE PATIENTS; HODGKIN LYMPHOMA; UNITED-STATES; BREAST-CANCER;
D O I
10.1093/cid/cis613
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Since the advent of HAART, patients with HIV infection have seen a significant improvement in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses, including AIDS-defining malignancies, has been on the decline. However, deaths due to non-AIDS-defining illnesses have been on the rise. These so-called non-AIDS-defining cancers (NADCs) include cancers of the lung, liver, kidney, anus, head and neck, and skin, as well as Hodgkin's lymphoma. It is poorly understood why this higher rate of NADCs is occurring. The key challenge facing oncologists is how to administer chemotherapy effectively and safely to patients on antiretroviral therapy. The challenge to clinicians caring for HIV-infected patients is to develop and implement effective means to screen, treat, and prevent NADCs in the future. This review presents data on the epidemiology and etiology of NADCs, as well as ongoing research into this evolving aspect of the HIV epidemic.
引用
收藏
页码:1228 / 1235
页数:8
相关论文
共 88 条
[1]
The changing face of HIV care: Common things really are common [J].
Aberg, Judith A. .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (06) :463-465
[2]
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].
Aberle, Denise R. ;
Adams, Amanda M. ;
Berg, Christine D. ;
Black, William C. ;
Clapp, Jonathan D. ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine ;
Marcus, Pamela M. ;
Sicks, JoRean D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409
[3]
Recommended Adult Immunization Schedule: United States, 2012 Advisory Committee on Immunization Practices [J].
Baker, Carol J. ;
Bennett, Nancy ;
Bocchini, Joseph A., Jr. ;
Campos-Outcalt, Douglas ;
Coyne-Beasley, Tamera ;
Duchin, Jeffrey ;
Ehresmann, Kristen R. ;
Jenkins, Renee R. ;
Keitel, Wendy A. ;
Marcy, Michael S. ;
Meissner, H. Cody ;
Rosenbaum, Sara ;
Sawyer, Mark H. ;
Temte, Jonathan ;
Vasquez, Marietta .
ANNALS OF INTERNAL MEDICINE, 2012, 156 (03) :211-U73
[4]
The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells [J].
Albini, A ;
Soldi, R ;
Giunciuglio, D ;
Giraudo, E ;
Benelli, R ;
Primo, L ;
Noonan, D ;
Salio, M ;
Camussi, G ;
Rockl, W ;
Bussolino, F .
NATURE MEDICINE, 1996, 2 (12) :1371-1375
[5]
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane [J].
Altavilla, G ;
Caputo, A ;
Trabanelli, C ;
Cofano, EB ;
Sabbioni, S ;
Menegatti, MA ;
Barbanti-Brodano, G ;
Corallini, A .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (02) :275-283
[6]
Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene [J].
Altavilla, G ;
Caputo, A ;
Lanfredi, M ;
Piola, C ;
Barbanti-Brodano, G ;
Corallini, A .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) :1081-1089
[7]
Effect of HIV-1 Vpr on cell cycle regulators [J].
Amini, S ;
Khalili, K ;
Sawaya, BE .
DNA AND CELL BIOLOGY, 2004, 23 (04) :249-260
[8]
[Anonymous], CHANT PACK INS
[9]
Interactions between antiretrovirals and antineoplastic drug therapy [J].
Antoniou, T ;
Tseng, AL .
CLINICAL PHARMACOKINETICS, 2005, 44 (02) :111-145
[10]
MICROSATELLITE INSTABILITY IN PRIMARY NEOPLASMS FROM HIV+ PATIENTS [J].
BEDI, GC ;
WESTRA, WH ;
FARZADEGAN, H ;
PITHA, PM ;
SIDRANSKY, D .
NATURE MEDICINE, 1995, 1 (01) :65-68